David Norcliffe MMedSci, CSci (retired) FIBMS (retired) DM
- Rosencranz R, Bogen SA. Clinical laboratory measurement of serum, plasma, and blood viscosity. Am J Clin Pathol. 2006;125 Suppl:S78-S86. doi:10.1309/FFF7U8RRPK26VAPY
- Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754. Published 2018 Apr 13. doi:10.3389/fimmu.2018.00754
- Orr CK, Najm A, Young F, et al. The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis. Front Med (Lausanne). 2018;5:185. Published 2018 Aug 3. doi:10.3389/fmed.2018.00185
- Orr et al, The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis. Lausanne, Switzerland : Frontiers Media S.A., [2018]- Aug 3;5:185
- Gleghorn DM, Olayiwola O, Omer A, Lynn R, Norcliffe D, Robinson M. Diagnostic value of plasma viscosity testing for patients with COVID-19. Int J Lab Hematol. 2021;43(4):O227-O229. doi:10.1111/ijlh.13532
- Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?. Lancet. 2020;395(10239):1758-1759. doi:10.1016/S0140-6736(20)31209-5
- Somer, T. (1987) Rheology of paraproteinaemias and plasma hyperviscosity syndrome. In: Bailliere's Clinical Haematology, 1 (3), pp. 695-723.
- Somer, T. (1966) The viscosity of blood plasma, and serum in dys- and Paraproteinemias. Acta Medica Scandinavica. Supplementum, 180 (S456), pp. 5-97.
- Thuyan, T. (2013) Waldenstrom’s Magroglobulinemia: a review of laboratory findings and clinical aspects. Laboratory Medicine, 44 (2), pp. e19-e21.
- Menka, MN., Feke, GT., McMeel, JW., Branagan, A., Hunter, Z. and Treon, SP. (2006) Hyperviscosity-related retinopathy in Waldrenstrom Macroglobulinemia. Archives of Ophthalmology, 124 (11), pp. 1601-1606.
- MacKenzie MR, Fudenberg HH. Macroglobulinemia: an analysis for forty patients. Blood. 1972;39(6):874-889.
- NICE (2020) Multiple myeloma [online] available at: https://cks.nice.org.uk/topics/multiple-myeloma/ [accessed 24/12/2020].
- Rogers, AP. and Estes, M. (2020) Hyperviscosity syndrome. In, StatPearls [online] Treasure Island: StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK518963/ [accessed 17/12/2020].
- Harkness, J. (1981) Measurement of plasma viscosity. In Lowe, GDO., Barbenel, JC. and Forbes, CD. (1981) Clinical aspects of blood viscosity and cell deformability. Berlin: Springer-Verlag, pp. 79-87.
- Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost. 2003;29(5):467-471. doi:10.1055/s-2003-44554
- MacKenzie MR, Fudenberg HH, O'Reilly RA. The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape. J Clin Invest. 1970;49(1):15-20. doi:10.1172/JCI106213
- Rosencranz R, Bogen SA. Clinical laboratory measurement of serum, plasma, and blood viscosity. Am J Clin Pathol. 2006;125 Suppl:S78-S86. doi:10.1309/FFF7U8RRPK26VAPY
- Delivanis, D., Datta, D (2013) Acute Myeloid Leukemia presenting with Leukostasis and Hyperviscosity Syndrome. Critical Care Medicine, 41(12), pp. A335
- Geraci JM, Hansen RM, Kueck BD. Plasma cell leukemia and hyperviscosity syndrome. South Med J. 1990;83(7):800-805. doi:10.1097/00007611-199007000-00020
- Dwyer-Joyce, LEA., Swami, VK., (2000) Diagnosing Plasma Cell Leukemia. Laboratory Medicine, 31(6) pp. 312-315.
- Coull BM, Beamer N, de Garmo P, et al. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke. 1991;22(2):162-168. doi:10.1161/01.str.22.2.162
- Kwaan HC. Hyperviscosity in plasma cell dyscrasias. Clin Hemorheol Microcirc. 2013;55(1):75-83. doi:10.3233/CH-131691
- Harreby M, Danneskiold-Samsøe B, Kjer J, Lauritzen M. Viscosity of plasma in patients with rheumatoid arthritis. Ann Rheum Dis. 1987;46(8):601-604. doi:10.1136/ard.46.8.601
- Gudmundsson M, Bjelle A. Plasma viscosity in the monitoring of therapy in rheumatoid arthritis patients. Scand J Rheumatol. 1995;24(4):219-224. doi:10.3109/03009749509100877
- Pickup ME, Dixon JS, Hallett C, Bird HA, Wright V. Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis. Ann Rheum Dis. 1981;40(3):272-275. doi:10.1136/ard.40.3.272
- Bull BS, Levy WC, Westengard JC, et al. Ranking of laboratory tests by consensus analysis. Lancet. 1986;2(8503):377-380. doi:10.1016/s0140-6736(86)90063-2
- Cowan IC, Harkness J. The plasma viscosity in rheumatic diseases. Br Med J. 1947;2(4530):686-688. doi:10.1136/bmj.2.4530.686
- Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis. 2001;60(11):1021-1024. doi:10.1136/ard.60.11.1021
- NICE (2019) Polymyalgia rheumatica [online] available at: https://cks.nice.org.uk/topics/polymyalgia-rheumatica/ [accessed 23/12/2020].
- Mackie SL, Hensor EM, Haugeberg G, Bhakta B, Pease CT. Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford). 2010;49(4):716-722. doi:10.1093/rheumatology/kep395
- Mackie, SL. and Mallen, CD. (2013) Polymyalgia rheumatica. British Medical Journal, 347, pp. 26-30.
- Esselinckx W, Bucknall RC, Dixon AS. Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity. Ann Rheum Dis. 1977;36(6):560-562. doi:10.1136/ard.36.6.560
- Speed CA, Haslock I. Polymyalgia rheumatica, temporal arteritis and malignancy. Postgrad Med J. 1995;71(838):500-502. doi:10.1136/pgmj.71.838.500
- Finke C, Schroeter J, Kalus U, Ploner CJ. Plasma viscosity in giant cell arteritis. Eur Neurol. 2011;66(3):159-164. doi:10.1159/000331059
- Gudmundsson M, Nordborg E, Bengtsson BA, Bjelle A. Plasma viscosity in giant cell arteritis as a predictor of disease activity. Ann Rheum Dis. 1993;52(2):104-109. doi:10.1136/ard.52.2.104
- NHS (2018) Cardiovascular disease [online] available at: https://www.nhs.uk/conditions/cardiovascular-disease/ [accessed 09/12/2020].
- Dintenfass, L. (1985) Blood Viscosity. Lancaster: MTP Press Limited.
- Mayer GA. Blood viscosity in healthy subjects and patients with coronary heart disease. Can Med Assoc J. 1964;91(18):951-954.
- Peters SA, Woodward M, Rumley A, Tunstall-Pedoe HD, Lowe GD. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. Eur J Prev Cardiol. 2017;24(2):161-167. doi:10.1177/2047487316672004
- Lowe GD, Wood DA, Douglas JT, et al. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost. 1991;65(4):339-343.
- Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med. 1981;70(6):1195-1202. doi:10.1016/0002-9343(81)90827-5
- Otto C, Richter WO, Schwandt P. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism. 2000;49(6):810-813. doi:10.1053/meta.2000.6264
- Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438-e440. doi:10.1016/S2352-3026(20)30145-9
- Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-1120. doi:10.1515/cclm-2020-0188
- Sharma K, Puniyani RR, Bhat SV, Advani SH, Hegde U, Rao S. Blood viscosity parameter correlation with types of leukemia. Physiol Chem Phys Med NMR. 1992;24(2):159-164.